Copyright 2026 Cutback Coach, Inc. All rights reserved. 

Medication options and habit-change support, built around your drinking goals. Sunnyside Med is here for you.

Get started

Change your drinking using neuroscience & habit-change.

Sunnyside Med is here for you.

Powered by Sunnyside

Sunnyside’s text-based behavior-change program has been studied in peer-reviewed observational research.⁹ Sunnyside Med adds access to clinical assessment and medication options when appropriate, alongside tools and human support for working on your drinking goals.

Prescription treatment and compounded medications

*Sunnyside Med combines prescribed medication with app-based tools, coaching, and ongoing support. Full and Microdose programs pair daily semaglutide with daily naltrexone as two separate medications. Microdose uses lower prescribed doses. Semaglutide is not offered on its own; naltrexone-only treatment is a separate program. Your online evaluation helps identify a program, and a licensed provider makes the final prescribing decision. An assessment or payment does not guarantee a prescription.

Both medications offered through Sunnyside Med are compounded and are not FDA-approved. FDA does not review compounded medications for safety, effectiveness, or quality before marketing.⁴ FDA approval of naltrexone tablets does not extend to our compounded naltrexone.⁶,⁷ Semaglutide is not FDA-approved to treat alcohol use disorder.⁵

Sunnyside provides the technology platform and nonclinical support; your licensed healthcare provider handles clinical decisions and prescribing. Medications are prepared and dispensed by a partner pharmacy, not Sunnyside. Your dispensing pharmacy is identified on your medication label. Bottle illustrations are not actual dispensing labels; packaging and medication appearance may vary. Follow your prescription labels and your provider’s instructions.

Important Safety Information

Before starting, tell your provider about your medical history, allergies, all medications and supplements, and any pregnancy or breastfeeding plans. Do not use a medication if you have had a serious allergic reaction to it or its ingredients.⁵,⁷,¹⁵

Semaglutide: Semaglutide caused thyroid C-cell tumors in animal studies; whether it causes these tumors in humans is unknown. Do not use semaglutide if you or a family member has had medullary thyroid carcinoma, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Contact your provider for a neck lump, persistent hoarseness, or difficulty swallowing.⁵

Other important risks include pancreatitis, gallbladder problems, severe digestive symptoms, and kidney injury related to dehydration. Low blood sugar risk increases when used with insulin or certain diabetes medicines, such as sulfonylureas. Tell your provider about severe stomach-emptying problems, diabetic eye disease, and kidney, pancreas, or gallbladder problems.⁵,¹⁵

Semaglutide may affect absorption of oral medicines. Tell your healthcare team before surgery or procedures involving anesthesia or deep sedation. Contact your provider if you become pregnant; semaglutide should be stopped at least two months before a planned pregnancy. Discuss breastfeeding with your provider before treatment.⁵,¹⁵

Naltrexone: Do not start naltrexone while using opioids, after recent opioid use, or during opioid withdrawal. Tell your provider about opioid pain or cough medicines, tramadol, methadone, buprenorphine, kratom, and any other opioid use. Your provider must determine a safe opioid-free interval. Naltrexone can trigger sudden, severe opioid withdrawal and block opioid pain medicines. Trying to overcome the blockade by taking more opioids can cause a fatal overdose. Opioid sensitivity may increase after stopping naltrexone. Tell doctors, dentists, and emergency clinicians that you take it. Liver injury and serious allergic reactions can occur.⁷

Possible side effects: Nausea, vomiting, diarrhea, constipation, stomach discomfort, decreased appetite, headache, dizziness, tiredness, and trouble sleeping. Tell your provider if symptoms persist, worsen, or interfere with daily life.⁵,⁷,¹⁵

When to get help: Seek urgent in-person care for severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, yellowing skin or eyes, or dark urine. Call 911 for trouble breathing, swelling of the face or throat, fainting, severe confusion, or other life-threatening symptoms. Report new or worsening mood changes promptly; seek emergency help for thoughts of self-harm.⁵,⁷,¹⁵

Alcohol withdrawal: These medications do not treat alcohol withdrawal. If you drink heavily or have had withdrawal, get medical advice before cutting back or stopping suddenly. Shaking, sweating, or needing alcohol to feel normal after cutting back requires urgent in-person assessment—not just an app message. Seizures, hallucinations, or severe confusion require emergency care.¹⁰

This is a summary, not a complete list of risks or side effects. Read the information supplied with your prescription, follow your care plan, and contact your provider with questions. Safety references below concern approved products containing these active ingredients; they are not FDA-approved labeling or administration instructions for Sunnyside’s compounded medications. Sunnyside Med is not emergency or medically supervised alcohol-withdrawal care.

Research and results

Approved oral naltrexone has been studied alongside clinical management and behavioral support.⁸,¹³ Those findings concern the studied formulations and regimens, not Sunnyside’s compounded combination.

Semaglutide trials have reported improvements in some drinking and craving measures, but not every outcome.¹–³ These studies used injected or standard swallowed formulations—not Sunnyside’s compounded dissolvable tablet or this semaglutide-and-naltrexone combination. They do not establish the effectiveness of our formulation or that this combination works better than either medication alone.

Broader GLP-1 research also has limitations: an exenatide trial did not significantly improve its primary heavy-drinking outcome overall, and observational semaglutide studies report associations rather than proof of cause and effect.¹¹,¹²

The 33% result concerns Sunnyside’s behavior-change program, not medication treatment.⁹ The approximately 45% result comes from selected participants in an earlier Sunnyside Med program, not the new combination.¹⁴ These observational, self-reported results do not establish that the programs caused the changes or predict individual results. Research publications and professional affiliations do not constitute endorsements of Sunnyside or its compounded medications.

Billing and membership

Full costs $299 every 28 days in three automatic installments per 84-day membership and medication shipment: $897 total. Microdose costs $199 every 28 days in three installments: $597 total per 84-day period. A one-time $50 intake fee is additional. If prescribed, the full 84-day medication supply ships together. All three installment payments are required for each shipment received; these are not cancel-anytime monthly subscriptions.

Naltrexone-only costs $297 billed quarterly, equivalent to $99 per month, plus the one-time $50 intake fee. No insurance is required. Memberships renew automatically unless cancelled under the applicable terms. To request cancellation of future renewals, text your Sunnyside number or email
support@sunnyside.co. Review renewal, cancellation, and refund terms before purchasing. Cancellation of future renewals does not, by itself, remove the installment obligation for a shipment already received, subject to applicable law and refund terms.

Availability and contact

Clinical services and medication options depend on your location and clinical eligibility and may change. Confirm availability during enrollment. A provider may recommend a different program or in-person care when appropriate.

Questions about the program? Email med@sunnyside.co. Do not use email or app messaging for emergencies; call 911 or seek emergency care.


Partner Pharmacies

Triad Rx

26258 Pollard Rd, Daphne, AL 36526


Foothills Professional Pharmacy

2727 W Baseline Rd #1, Tempe, AZ 85283


State coverage 


Currently offering services in all 50 states plus Washington D.C. Some services may not be available in all 50 states or Washington D.C. Subject to change.

Frequently asked questions

Starting a new medication is a big deal for anyone. We want you to feel comfortable and fully prepared. Here are some common questions we see.

What is Sunnyside Med?

Sunnyside Med combines prescribed medication with online clinical care, practical tools, and human support for changing your drinking. Your plan includes tracking, planning, coaching, and community support. Our online evaluation helps identify which medication program may be right for you, followed by a licensed provider’s review and prescribing decision.

How much does it cost, and how am I billed?

Full is $299 every 28 days, paid in three automatic installments for each 84-day membership and medication shipment: $897 total. Microdose is $199 every 28 days, also paid in three installments: $597 total per 84-day period. Both have a one-time $50 intake fee. If medication is prescribed, the full 84-day supply ships together, and all three payments are required for that shipment. These are installment plans, not cancel-anytime monthly subscriptions.

Naltrexone-only is $297 billed quarterly, equivalent to $99 per month, plus the one-time $50 intake fee. No insurance is required. Review the applicable renewal, cancellation, and refund terms before enrolling.

Which medications might be included in my plan?

Full and Microdose both include two separate daily medications: compounded semaglutide and compounded naltrexone. Microdose uses lower prescribed doses. Semaglutide is a dissolvable tablet and naltrexone is a capsule—not one combination pill. We do not offer semaglutide alone. If the combination program isn’t appropriate for you, a separate naltrexone-only program may be recommended. Our online evaluation helps identify a program; a licensed provider makes the prescribing decision. Starting an assessment does not guarantee a prescription.*

What side effects and safety considerations should I know about?

Possible side effects include nausea, vomiting, bowel changes, stomach discomfort, decreased appetite, headache, dizziness, and tiredness. Important risks include severe stomach symptoms, pancreas or gallbladder problems, dehydration-related kidney injury, liver injury, and allergic reactions.⁵,⁷,¹⁵ Naltrexone must not be started during opioid use or withdrawal. Semaglutide is not appropriate for people with certain thyroid-cancer histories or MEN 2.⁵,⁷ Review the Important Safety Information below and discuss your medical history and medications with your provider before starting.

Are these medications FDA-approved?

No. The compounded medications offered through Sunnyside Med are not FDA-approved and have not undergone FDA premarket review for safety, effectiveness, or quality.⁴ FDA-approved naltrexone tablets are used for alcohol dependence, but that approval does not extend to our compounded medication.⁶,⁷ Semaglutide is not FDA-approved to treat alcohol use disorder.⁵

Do I have to stop drinking before I start?

Not everyone needs to stop drinking completely before starting a prescribed plan. Your provider will discuss your goals and how to make changes safely. If you drink heavily, have had withdrawal, or feel shaky or sweaty when cutting back, get medical guidance before reducing or stopping. These medications do not treat alcohol withdrawal, which can be dangerous. Seizures, hallucinations, or severe confusion require emergency care.¹⁰

How do I know whether this program is right for me?

You can start an assessment without a prior diagnosis. Medication eligibility is limited to adults ages 21–74 and depends on your location, drinking pattern, medical history, medications, and other clinical criteria, including weight/BMI for GLP-1 treatment. Your provider may recommend different treatment or in-person care instead. This program is not emergency or medically supervised withdrawal care.

What does the research say about these medications?

Approved oral naltrexone has a substantial research history in alcohol care.⁶–⁸,¹³ Semaglutide research is newer: studies have found improvements in some drinking and craving measures, but not every outcome.¹–³ Those trials studied injected or standard swallowed semaglutide, not Sunnyside’s compounded formulation or its combination with naltrexone. They do not establish that this program’s combination works better than either medication alone. Individual responses vary.

What support comes with the program?

You’ll have drink tracking, weekly planning, coaching, educational resources, and community support, alongside access to your clinical care team. The tools help you notice patterns and put your goals into practice. Coaching and community are not substitutes for medical care, emergency services, or a higher level of treatment when needed.

How long would I take medication?

There is no single medication timeline for everyone. Your provider will review your response, side effects, health history, and goals and decide with you whether to continue, adjust, or stop treatment. Building new habits can take time, but a long-term habit-change plan is not a requirement to take the same medications or doses for a fixed year. Follow your provider’s instructions rather than changing treatment on your own.

Med reminders

Build taking medication as prescribed into your routine with reminders and medication logging.

Community

Give and get support from people working on their own drinking goals.

Coaching

Connect with a real person when you want encouragement or help putting your plan into practice.

Progress

Review your drink tracking and patterns over time so you can see what’s changing.

Resources

Explore educational tools and practical strategies for changing drinking habits.

Drink tracking

Log your drinks and use that information to make a plan for the week ahead.

Medication alone isn’t enough.

We combine neuroscience with behavior change.

Changing your drinking also means working with the routines around it. That’s why Sunnyside Med pairs clinical care and medication options with drink tracking, planning, coaching, and community support. Sunnyside’s text-based behavior-change program has been studied in published observational research.⁹

Take the assessment

Answer a few questions about your drinking goals and health history to start exploring whether Sunnyside Med is right for you.

Licensed care team review

After your health intake, a licensed clinician will review your intake and, if appropriate, write a prescription.

Medication delivery & program start

If approved, your compounded prescription is shipped to your door and we help guide you from day one.

TAKE CHARGE OF YOUR DRINKING

What to expect.
Getting started is simple.

Sunnyside Med takes a personal, holistic approach to drinking less, so it’s easier to cut back without relying on willpower alone.

Medication from a licensed provider
Built for long-term change, not quick fixes
Designed for moderation goals

Guided by experts, grounded in real science

TAKE CHARGE OF YOUR DRINKING

No shame. No pressure. Just guidance that works.

You don’t have to figure this out alone. Clinical care, practical tools, and human support can all be part of your plan. Sunnyside Med brings them together around your drinking goals.

You don’t have to rely on willpower to drink less or quit.

USE SCIENCE TO DRINK LESS

Change you can measure.
Over 600,000 members helped to date.

report drinking less16

Self-reported data from customer survey (not tied directly to compounded medication)

average reduction in drinks14

Sunnyside Med customers on the naltrexone-only program after 12 weeks of use.

binge drink less16

Self-reported data from customer survey (not tied directly to compounded medication)

You don’t need a prior diagnosis or a rock-bottom moment to start an assessment. Sunnyside Med is for people who want to explore changing their relationship with alcohol. A licensed provider will review whether this level of care is appropriate for you.

You’re not sure your drinking is “bad enough”—but you’d like support.

You’ve tried cutting back on your own and want another approach.

You want to explore online clinical care alongside habit-change support.

You’d prefer needle-free medication options, if appropriate for you.

Built specifically for the gray-area drinker.

TAKE CHARGE OF YOUR DRINKING

Two medications. 
One personalized plan. Drink less or quit.

For eligible adults, our combination program includes semaglutide and naltrexone as two separate medications, both taken daily as prescribed by a licensed provider, alongside Sunnyside’s app, coaching, and care-team support—all built around your drinking goals.*

NEW FROM SUNNYSIDE MED

LegitScript Certified
Verified online healthcare merchant

Important information from Sunnyside: Early semaglutide research shows promise for alcohol cravings, but those studies did not test our compounded dissolvable tablet or its combination with naltrexone.¹–³ Our medications are compounded and are not FDA-approved.⁴ Semaglutide is not FDA-approved for alcohol use disorder.⁵ Bottle images are illustrations; actual packaging may vary. Medications are compounded and dispensed by a partner pharmacy, not Sunnyside. Questions? We’re here at med@sunnyside.co. 

NEEDLE-FREE         •         CLINICIAN-PRESCRIBED         •         100% ONLINE         •         ONCE DAILY         •         NO INSURANCE REQUIRED         •         MODERATION OR SOBRIETY

       • NEEDLE-FREE  • DOCTOR PRESCRIBED 
• 100% ONLINE • ONCE DAILY 
• NO INSURANCE REQUIRED 
• MODERATION OR SOBRIETY

Built on emerging research

Clinical studies of semaglutide have reported improvements in some alcohol-related outcomes.¹–³

Semaglutide (GLP-1)

FOR ALCOHOL URGES

New research. 
Personalized care.

Early clinical research suggests semaglutide may help quiet alcohol cravings and reduce heavy drinking—a promising new direction for people who want to drink less.¹–³*

A GLP-1 medication involved in appetite and fullness.⁵

Being studied for alcohol use disorder.¹–³

Prescribed only when your provider considers it appropriate.*

Appetite and weight changes may occur; tell your care team what you notice.⁵

New research. Personalized care.

FOR ALCOHOL URGES

Naltrexone

FOR ALCOHOL REWARD

Naltrexone may make alcohol feel less rewarding by blocking opioid receptors.⁶ Research supports approved oral naltrexone alongside behavioral support.⁷,⁸,¹³ Our compounded formulation is not FDA-approved.*

FDA-approved naltrexone tablets have been used for AUD since 1994.⁶

Blocks opioid receptors involved in alcohol’s reward.⁶

Studied in clinical trials of alcohol use disorder.⁸,¹³

Your provider reviews side effects and whether continued use is appropriate.⁷

Targets alcohol’s reward pathways.⁶

FOR ALCOHOL REWARD

Two separate medications. 
One personalized care plan.

Our combination program pairs daily semaglutide with daily naltrexone as two separate medications. Our online evaluation helps identify which program may be right for you; a licensed provider then reviews your information and determines whether to prescribe. One coordinated care plan—not a one-size-fits-all prescription.*

Your provider determines which treatment is appropriate for you. If both medications are prescribed, they are taken separately. Follow your prescription labels for formulation, dose, timing, and administration. Both medications offered through this program are compounded and are not FDA-approved.*

SEE IF YOU QUALIFY

Psychology & Neuroscience

A structured approach to breaking old habits and building new ones in their place.

Modern Preventive Medicine

A licensed provider reviews your health history and recommends medication only when appropriate.

Clinical care & connection

Community and human coaching to build resilience through any ups and downs along the way.

Getting support for your drinking shouldn’t take years. Sunnyside Med is on a mission to close the gap between wanting to make a change and getting help.

Sunnyside Med is way more than just medication.

Our program brings clinical care, medication options, and habit-change support into one personalized plan. When appropriate, a provider may prescribe compounded semaglutide and compounded naltrexone as two separate medications. The app, coaching, and community give you practical ways to work on the routines around drinking.*

Meet our clinical advisors

Our clinical advisors bring experience in psychology, alcohol research, harm reduction, and medical care. Your personal treatment decisions are made by your licensed prescribing clinician.

Alcohol Use Disorder

Dr. Nehal Vadhan, PhD

Associate Professor of Psychiatry at the Zucker School of Medicine at Hofstra/Northwell, where he directs research on substance use and problem drinking. He has led multiple clinical studies of brief, telehealth-based interventions for alcohol — the science behind programs like Sunnyside.

Clinical Psychologist & Addiction Researcher, Hofstra/Northwell

Psychology

Dr. Hayley Treloar Padovano, PhD

Addiction Scientist, Brown University

Associate Professor of Psychiatry and Human Behavior and of Behavioral and Social Sciences at Brown University. Her research examines substance use, alcohol cravings, and ways to improve screening and interventions.

Harm Reduction Expert

Dr. Andrew Tatarsky, PhD

Founder, Center for Optimal Living,
Creator of IHRP

Clinical psychologist who created Integrative Harm Reduction Psychotherapy and founded the Center for Optimal Living. For three decades he's championed meeting people where they are — moderation or abstinence, without judgment — the exact philosophy behind "your choice."

Practicing Doctor

Dr. Hrishikesh Belani, MD, MPH

Board-Certified Internal & Addiction Medicine Physician

Board-certified internist specializing in addiction medicine, and primary care director for the LA County Health Services Ambulatory Care Network. He's spent his career widening access to evidence-based substance-use care in one of the nation's largest public health systems.

JOIN SUNNYSIDE MED

NEW FROM SUNNYSIDE MED

Two medications. 
One personalized plan. Drink less or quit.

For eligible adults, a licensed provider may prescribe semaglutide and naltrexone as two separate medications, alongside Sunnyside’s app, coaching, and care-team support.

Start your assessment

LegitScript Certified
Verified online healthcare merchant

NEEDLE-FREE         •         DOCTOR PRESCRIBED         •         100% ONLINE         •         ONCE DAILY         •         NO INSURANCE REQUIRED         •         MODERATION OR SOBRIETY

• NEEDLE-FREE
• DOCTOR PRESCRIBED
• 100% ONLINE

• ONCE DAILY  
• NO INSURANCE REQUIRED
• MODERATION OR SOBRIETY

NEW FROM SUNNYSIDE MED

If you drink heavily or have experienced withdrawal, seek medical advice before cutting back or stopping suddenly. This program is not emergency or alcohol-withdrawal care.¹⁰

¹ Hendershot CS et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82:395–405. Read study. Nine-week trial of injected semaglutide in 48 adults; improvements in weekly craving and some drinking measures, but not average drinks per calendar day or drinking-day frequency.

² Klausen MK et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. The Lancet. 2026;407:1687–1698. Read study. Twenty-six-week trial in 108 adults with AUD and obesity; weekly injected semaglutide plus cognitive behavioral therapy reduced heavy-drinking days more than placebo plus therapy.

³ Schacht JP et al. Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial. American Journal of Psychiatry. 2026;183:636–645. Read study. Eight-week trial in 50 adults using standard swallowed oral semaglutide. Heavy-drinking days and some exploratory measures improved; the primary laboratory craving outcome and drinks per day did not significantly improve versus placebo.

⁴ US Food and Drug Administration. Understanding the Risks of Compounded Drugs. FDA information. Explains compounded-drug approval status and the absence of FDA premarket review.

⁵ FDA-approved semaglutide tablet prescribing information and Medication Guide. DailyMed. Reference for approved indications, mechanism, and important safety information—not approval or administration instructions for Sunnyside’s compounded tablet.

⁶ National Institute on Alcohol Abuse and Alcoholism. Medications Development Program. NIAAA information. Oral naltrexone approval history and its opioid-receptor mechanism.

⁷ Naltrexone hydrochloride tablet prescribing information. DailyMed. Approved-product contraindications, opioid withdrawal and overdose risks, liver warnings, and other safety information—not FDA approval of Sunnyside’s compound.

⁸ Anton RF et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003–2017. Read study. Studied oral naltrexone with medical management and other treatments; not Sunnyside, semaglutide, or our compounded combination.

⁹ Vadhan NP et al. Self-reported alcohol consumption during participation in a text messaging-based online drinking moderation platform. Alcohol: Clinical and Experimental Research. 2024;48:1784–1794. Read study. Observational analysis of 46,411 Sunnyside users reported a 33% decrease in weekly drink counts over 12 weeks. Self-reported data; no randomized control group; not a medication trial.

¹⁰ National Library of Medicine, MedlinePlus. Alcohol withdrawal. Patient information. Withdrawal symptoms, medical assessment, and emergency warning signs.

¹¹ Klausen MK et al. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. 2022;7. Read study. The primary heavy-drinking outcome was not significantly improved overall; obesity-subgroup findings were exploratory. Exenatide is not semaglutide.

¹² Wang W et al. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nature Communications. 2024;15:4548. Read study. Retrospective electronic-health-record study; associations do not establish that semaglutide caused the observed differences.

¹³ McPheeters M et al. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA. 2023;330:1653–1665. Read review. Supports studied oral naltrexone regimens alongside psychosocial interventions; does not evaluate Sunnyside’s compounded medications or combination.

¹⁴ Sunnyside internal observational program data; data on file. Approximately 45% average decrease in daily drinks over 12 weeks among selected participants in an earlier Med-First cohort who tracked drinking on more than half of days. Self-reported, nonrandomized data; selection and missing follow-up can affect results. Not results from the new semaglutide-and-naltrexone program. Individual results vary.

¹⁵ National Library of Medicine, MedlinePlus. Semaglutide Injection. Patient information. Additional semaglutide safety information; concerns approved injected products, not instructions for taking Sunnyside’s compounded tablet.

¹⁶ Sunnyside customer survey. Self-reported survey results, not results from a study of Sunnyside’s compounded medications. Individual results vary.